Loading...
Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, is typified by both motor and nonmotor symptoms. The current medications provide symptomatic relief but do not stimulate the production of new dopaminergic neurons in the substantia nigra. Astrocyte reprogramming has rec...
Na minha lista:
| Udgivet i: | Sci Adv |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Association for the Advancement of Science
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221613/ https://ncbi.nlm.nih.gov/pubmed/34162545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abg3198 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|